Patients with NSMP (as identified by an IHC-based on molecular classifier) endometrial cancer with mutant KRAS and wt ARID1A showed poor RFS compared with those with other KRAS/ARID1A statuses. This evidence concerns the gene KRAS and endometrial cancer.